Radiation-induced Nausea and Vomiting
📧 Sign up to get email alerts when something new happens for Radiation-induced Nausea and Vomiting.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-04-15FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Onesource Specialty Pharma Limited)
The FDA approved a supplemental application for ondansetron hydrochloride, a generic antiemetic, with Onesource Specialty Pharma Limited as …
-
FDA approval · 2026-04-15FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Onesource Specialty Pharma Limited)
The FDA approved a supplemental application for ondansetron hydrochloride from Onesource Specialty Pharma Limited under ANDA078257.
-
FDA approval · 2026-04-03FDA Approved: ONDANSETRON — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for Ondansetron submitted by PAI Holdings, LLC dba PAI Pharma (ANDA078127). This action confirms reg…
-
FDA approval · 2026-02-25FDA Approved: ONDANSETRON — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approves a supplemental application for a generic ondansetron hydrochloride product from Dr. Reddy's Laboratories Limited.
-
FDA approval · 2025-11-18FDA Approved: ONDANSETRON — Supplemental Application (Hospira, Inc.)
FDA granted Hospira, Inc. a supplemental approval for ondansetron (ONDANSETRON) under an ANDA.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-11-17FDA Approved: ONDANSETRON — Supplemental Application (JVET PHARMACEUTICALS LLC)
FDA approved a supplemental application for ondansetron from JVET Pharmaceuticals LLC under an ANDA (generic). The approval covers the use o…
-
FDA approval · 2025-09-16FDA Approved: ONDANSETRON — Supplemental Application (Qilu Pharmaceutical Co., Ltd.)
FDA approved a supplemental application for ondansetron from Qilu Pharmaceutical Co., Ltd. under ANDA203711.
-
FDA approval · 2025-09-09FDA Approved: ONDANSETRON — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
The FDA approved Glenmark's supplemental application for ondansetron, resulting in an approval update to its existing product labeling/indic…
-
FDA approval · 2024-07-08FDA Approved: ONDANSETRON — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for a generic ondansetron hydrochloride product submitted by Fresenius Kabi USA, LLC.
-
FDA approval · 2024-01-31FDA Approved: ONDANSETRON — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for ondansetron from Rising Pharma Holdings, Inc., indicating an approved change to the generic's la…
-
FDA approval · 2023-05-24FDA Approved: ONDANSETRON — Supplemental Application (Accord Healthcare, Inc.)
FDA approved a supplemental application for Ondansetron, manufactured by Accord Healthcare, Inc., signaling an update to its regulatory stat…
-
FDA approval · 2023-05-01FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Onesource Specialty Pharma Limited)
The FDA approved a supplemental application for ondansetron hydrochloride from Onesource Specialty Pharma Limited, approving this generic an…
-
FDA approval · 2022-11-09FDA Approved: ONDANSETRON HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for ondansetron hydrochloride from Sun Pharmaceutical Industries, Inc., under an ANDA. This docu…
-
FDA approval · 2022-11-09FDA Approved: ONDANSETRON — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approves Sun Pharmaceutical Industries' supplemental application for ondansetron, an antiemetic. The approval indicates a change to the …
-
FDA approval · 2022-08-22FDA Approved: GRANISETRON HYDROCHLORIDE — Supplemental Application (Natco Pharma Limited)
FDA approves a supplemental application for granisetron hydrochloride from Natco Pharma Limited.
-
FDA approval · 2022-06-14FDA Approved: ONDANSETRON — Supplemental Application (AvPAK)
FDA approved a supplemental application for ondansetron from AvPAK.
-
FDA approval · 2022-06-10FDA Approved: ONDANSETRON — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for ondansetron hydrochloride filed by Fresenius Kabi USA, LLC.
-
FDA approval · 2022-06-10FDA Approved: ONDANSETRON — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for ondansetron hydrochloride (ondansetron), a generic product manufactured by Fresenius Kabi USA, L…
-
FDA approval · 2022-03-15FDA Approved: ONDANSETRON — Supplemental Application (Hospira, Inc.)
FDA approves Hospira, Inc.'s supplemental application for ondansetron, authorizing changes to the approved product.
-
FDA approval · 2022-03-15FDA Approved: ONDANSETRON — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for ondansetron from Hospira, Inc., updating the product's approval under the ANDA.
-
FDA approval · 2022-03-11FDA Approved: ONDANSETRON — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved a supplemental application for a generic ondansetron product from Heritage Pharmaceuticals (Avet) under the ANDA process.
-
FDA label_change · 2022-02-28FDA Approved: ONDANSETRON — Supplemental Application (Qilu Pharmaceutical Co., Ltd.)
FDA approved a supplemental application for ondansetron from Qilu Pharmaceutical Co., Ltd., likely resulting in labeling changes for this ge…
-
FDA approval · 2021-10-01FDA Approved: ONDANSETRON — Supplemental Application (AvPAK)
The FDA approved a supplemental application for ondansetron submitted by AvPAK.
-
FDA approval · 2021-09-01FDA Approved: ONDANSETRON — Supplemental Application (Qilu Pharmaceutical Co., Ltd.)
FDA approved a supplemental application for ondansetron submitted by Qilu Pharmaceutical Co., Ltd. (ANDA 203711).
-
FDA approval · 2021-08-19FDA Approved: ONDANSETRON — Supplemental Application (Eugia US LLC)
FDA approved a supplemental ANDA from Eugia US LLC for ondansetron hydrochloride (ondansetron), establishing a generic product.